Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0020538 (hypertension)
 170,190 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We studied 16 patients of abdominal aortic occlusion by digital subtraction angiography (DSA) in order to assess the advantages and limitations of Intravenous (IV) and Intra-arterial (IA) imaging in this rare clinical setting. All the patients had systemic hypertension and 14 patients (87.5%) also had associated coronary artery disease. Ten patients underwent IV-DSA and all were diagnostic. Eight of them had "stable" angina and, of these three patients (37.5%) developed clinical features of angina pectoris 5 to 10 minutes after the study. The remaining 6 patients who had "unstable" angina underwent an uneventful IA-DSA by transbrachial route. Intravenous DSA should be performed with caution since both the central venous contrast injection and Buscopan injection, used to control intestinal peristalsis, result in a transient increase in the cardiac workload, increase the myocardial oxygen demand and can precipitate myocardial ischaemia in the "high-risk" coronary patients. These patients should be electively studied by IA-DSA by transbrachial route inspite of the fact that IV-DSA examinations, if done, are usually diagnostic.
 ...
PMID:Invasive imaging of abdominal aortic occlusions: intravenous versus intra-arterial route. 207 76

We report on a patient with acute pancreatitis whose pain was resistant to simultaneous administration of morphine, procaine and Buscopan. This episode was complicated by development of hypertension, tachycardia, angina pectoris, ventricular arrhythmias and electrocardiographic modifications. Analgesia was provided by epidural administration of fentanyl and bupivacaine and brought about rapid resolution of all symptoms. The usefulness of epidural analgesia in acute pancreatitis is discussed.
 ...
PMID:[The value of epidural analgesia in acute pancreatitis]. 230 24

In 46 patients with biliary tract and pancreatic disorders, in which a diagnostic ERCP was performed, we used as premedication Propinoxate or hyoscine N-butyl bromide in a randomised, prospective study to demonstrate their effectiveness. This was achieved through the endoscopic evaluation, to determine the number of duodenal contractions observed 5 to 10 minutes after i.v. administration of the drugs, as well as the grade of distensibility of the intestinal folds and the occurrence or not of adverse reactions such as increased heart rate and hypertension. 25 patients received 20 mgs of hyoscine N-butyl bromide and the rest 5 mgs propinoxate, i.v. plus diazepam. 48% of patients in the first group and 42.9% in the second one, experienced optimum contractions (0 to 1) after 5 minutes; while after 10 minutes this difference was not significant (40% vs 38%). The incidence of adverse reactions, mainly increased heart rate, was higher for the first group (Hyoscine). Thirty minutes after there were not adverse reactions. We believe that propinoxate (PLIDAN) and hyoscine N-butylbromide, can be used in the pre-medication when performing ERCP.
 ...
PMID:[A clinical trial comparing propinoxate and hyoscine N-butylbromide in endoscopic retrograde cholangiopancreatography (ERCP)]. 818 80